Walmart agreed to pay $50 million to settle a Justice Department lawsuit accusing its pharmacies of improper opioid prescriptions, a fraction of its $11.7 billion net income over six months. The original threat of billions in penalties was reduced after a judge narrowed the case, strengthening Walmart's position. While the cash payment is small, the settlement includes stricter pharmacy oversight and ongoing monitoring to prevent future issues. This resolution slightly reduces legal risks but Walmart's broader opioid liabilities remain, and the company continues to show strong financial performance and growth in other areas.
The U.S. Department of Justice has broadened its antitrust investigation into beef prices to include eight major grocery retailers: Kroger, Publix, Walmart, Albertsons, Aldi, Ahold Delhaize, Costco, and Amazon. This follows an earlier probe into the ...
Walmart has agreed to a $50 million settlement after the DOJ and DEA accused its pharmacies of illegally filling thousands of opioid and controlled substance prescriptions since 2013. The complaint alleges Walmart pharmacists knowingly filled invalid...
